Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
source: pixabay.com

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

  According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

Continue Reading Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
Vektor Tests Generic Neupro Patch
Source: https://pixabay.com/en/band-aid-first-aids-injury-24298/

Vektor Tests Generic Neupro Patch

Have you ever heard of the Neupro patch? This transdermal delivery system directly delivers a dopamine agonist called rotigotine into the body. For patients with Parkinson's disease, restless legs syndrome,…

Continue Reading Vektor Tests Generic Neupro Patch
£1 Million Awarded For Parkinson’s Research on Mitochondria
argzombies / Pixabay

£1 Million Awarded For Parkinson’s Research on Mitochondria

According to the Parkinson’s News Today; in the UK, NRG Therapeutics has been awarded £1 million (about $1.3 million) to continue advancing their studies on the mitochondria responsible for producing…

Continue Reading £1 Million Awarded For Parkinson’s Research on Mitochondria
A PCORI Award Will Create a New Standard for Parkinson’s Palliative Care
source: pixabay.com

A PCORI Award Will Create a New Standard for Parkinson’s Palliative Care

  To capture the essence of palliative care, the World Health Organization defines it as the prevention and relief of suffering associated with a life-threatening illness. An article in Parkinson’s…

Continue Reading A PCORI Award Will Create a New Standard for Parkinson’s Palliative Care
MJFF Supports First Study of Anle138b for Parkinson’s
source: pixabay.com

MJFF Supports First Study of Anle138b for Parkinson’s

  Recently, the Michael J. Fox Foundation (MJFF) awarded $1.4 million in funding for Modag, a drug developer whose solutions treat patients with neurodegenerative diseases. In fact, says Parkinson's News…

Continue Reading MJFF Supports First Study of Anle138b for Parkinson’s
An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
source: pixabay.com

An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients

by Danielle Bradshaw from In The Cloud Copy A study was done to figure out how people with Parkinson’s disease coped with the illness in their day to day lives,…

Continue Reading An Observation of Differing and Overlapping Coping Mechanisms and Quality of Life Among Parkinson’s Patients
Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
source: pixabay.com

Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients

by Danielle Bradshaw from In The Cloud Copy Information provided by the Michael J. Fox Foundation showed that the majority of patients that had Parkinson’s disease and also contracted COVID-19…

Continue Reading Clash With COVID: Pandemic Negatively Impacts Parkinson’s Disease Patients
Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease
https://pixabay.com/photos/herbicide-avignon-in-rice-field-587589/

Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease

  Nobody knows the exact cause of Parkinson's disease. However, many researchers believe that environmental triggers may play a factor. Now, the Michael J. Fox Foundation (MJFF) is encouraging American…

Continue Reading Michael J. Fox Foundation Supports Bill to Ban Paraquat, a Chemical Linked to Parkinson’s Disease
Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19
source: pixabay.com

Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19

Parkinson’s UK is nonprofit organization striving to help Parkinson's disease research continue amidst this global pandemic. Their goal is to get clinical research, and specifically studies that necessitate patients participating…

Continue Reading Survey for Parkinson’s Disease Patients Evaluates How to Resume Clinical Studies Safely Amidst COVID-19

ACI-12589 Shows Promise for Diagnosing Parkinson’s and Related Diseases

  At the virtual Alzheimer's Association International Conference (AAIC), AC Immune reported positive preclinical trial data for ACI-12589, their forward-thinking diagnostic tool. ACI-12589 is a non-invasive alpha-synuclein positron emission tomography…

Continue Reading ACI-12589 Shows Promise for Diagnosing Parkinson’s and Related Diseases

Editor’s Choice: Stevens-Johnson Syndrome Awareness Month

Happy Friday! Did you know that August is Stevens-Johnson Syndrome Awareness Month? It's a type of severe skin reaction that often involves admission to a burn unit for treatment. We've…

Continue Reading Editor’s Choice: Stevens-Johnson Syndrome Awareness Month
Close Menu